HOPA News

HOPA News is the association news materials featuring clinical content, practice management information, pharmacy and association events, and news important to all pharmacists who work in hematology/oncology. The Editorial Board is composed of members who serve on the Publications Committee and act as writers, editors, and peer reviewers.

HOPA News Archive

New Horizons for Resectable Non-Small Cell Lung Cancer: Updates in Perioperative Treatment

Past Newsletters

2023

Lymphoma Bispecific T-cell Engagers’ Place in Therapy
Indication Withdrawls of Small Molecule Inhibitors from the Accelerated Approval Program
Importance of Cancer Pain Management
Putting All of Our Eggs in Baskets Trials: New Tumor-Agnostic Approvals

2022

Overcoming Challenges to Provide BiTe and Car T Cell Therapy at a Community Career Center
Clinical Trial Management in the Post-Pandemic Era:  Reflections of an Investigational Drug Service  on the Past Two Years
B-Cell Maturation Antigen Targeting CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
The Blood Stops Here: Management of  Pediatric Hemophilia in 2022

2021

The FDA Accelerated Approval Program:  A Double Edged Sword
Up in Flames: Burnout in Oncology Pharmacy
Vials of Hope:  COVID-19 Vaccines for Cancer Patients
Launching an Oral Chemotherapy Telehealth  Clinic Using the TAMER Model

2020

Oncology Pharmacy and COVID-19: Perspectives from an Early Epicenter
Pharmacist Led Oncology Programs
Canabidiol Oil for Cancer Patients: Nature's Best Remedy?
Early Detection Saves Lives: Updates on Cancer Screening